Literature DB >> 20184930

Optimized pulmonary gene transfection in mice by spray-freeze dried powder inhalation.

Kohta Mohri1, Tomoyuki Okuda, Asami Mori, Kazumi Danjo, Hirokazu Okamoto.   

Abstract

Spray-freeze drying (SFD) is anpan> attractive technpan>ique to prepare highly porous dry powders for inhalation. However, there have been few reports of its application to dry powder inhalers (DPIs). Therefore, in this study, we prepared dry plasmid DNA (pDNA) powders with different molecular ratios of chitosanpan> to pDNA (N/P ratios) by pan> class="Disease">SFD. All the pDNA powders were spherical and highly porous, with particles approximately 20-40microm in geometric diameter. The morphology changed little with the alteration of the N/P ratio. On electrophoresis, a band of linear pDNA was detected in the preparation without chitosan, suggesting the destabilization of pDNA through SFD. However, the addition of chitosan protected pDNA from destabilization. Moreover, the pDNA powders were evaluated for pulmonary gene transfection efficiency using an in vivo dual imaging technique for gene DPIs developed previously. Maximum gene expression was observed at 9-12h following pulmonary administration of the powders into mice. The powder with the N/P ratio of 10 had the highest gene transfection efficiency. A higher affinity of chitosan for pDNA and a smaller (approximately 100nm) pDNA/chitosan complex (N/Pf10) were found at pH 6.5 (in lung) than at pH 7.4 (in physiological conditions), suggesting that the effective compaction of pDNA by chitosan at the N/P ratio of 10 at pH 6.5 contributes to the gene transfection efficiency in the lung. These results suggest inhalable dry pDNA powders with chitosan prepared by SFD to be a suitable formulation for pulmonary gene therapy. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184930     DOI: 10.1016/j.jconrel.2010.02.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.

Authors:  Jeannine M Refos; Alieke G Vonk; Marian T Ten Kate; Henri A Verbrugh; Irma A J M Bakker-Woudenberg; Wendy W J van de Sande
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Elucidation of the Mechanism of Increased Activity of Immunostimulatory DNA by the Formation of Polypod-like Structure.

Authors:  Kohta Mohri; Kengo Nagata; Shozo Ohtsuki; Shiori Toyama; Mao Nonomura; Yuki Takahashi; Yoshinobu Takakura; Makiya Nishikawa; Shinji Sakuma
Journal:  Pharm Res       Date:  2017-08-08       Impact factor: 4.200

3.  Delivery of pDNA Polyplexes to Bronchial and Alveolar Epithelial Cells Using a Mesh Nebulizer.

Authors:  Larissa Gomes Dos Reis; Maree Svolos; Lyn M Moir; Rima Jaber; Norbert Windhab; Paul M Young; Daniela Traini
Journal:  Pharm Res       Date:  2018-11-15       Impact factor: 4.200

4.  Inhalation performance of physically mixed dry powders evaluated with a simple simulator for human inspiratory flow patterns.

Authors:  Daiki Hira; Tomoyuki Okuda; Daisuke Kito; Kazunori Ishizeki; Toyoko Okada; Hirokazu Okamoto
Journal:  Pharm Res       Date:  2010-07-14       Impact factor: 4.200

5.  Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying.

Authors:  Feng Wan; Adam Bohr; Morten Jonas Maltesen; Simon Bjerregaard; Camilla Foged; Jukka Rantanen; Mingshi Yang
Journal:  Pharm Res       Date:  2012-12-11       Impact factor: 4.200

6.  Histological Quantification of Gene Silencing by Intratracheal Administration of Dry Powdered Small-Interfering RNA/Chitosan Complexes in the Murine Lung.

Authors:  Daisuke Ihara; Noboru Hattori; Yasushi Horimasu; Takeshi Masuda; Taku Nakashima; Tadashi Senoo; Hiroshi Iwamoto; Kazunori Fujitaka; Hirokazu Okamoto; Nobuoki Kohno
Journal:  Pharm Res       Date:  2015-07-03       Impact factor: 4.200

7.  Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.

Authors:  Hiroko Otake; Tomoyuki Okuda; Daiki Hira; Haruyoshi Kojima; Yasuhiro Shimada; Hirozazu Okamoto
Journal:  Pharm Res       Date:  2015-12-07       Impact factor: 4.200

8.  Drying of a plasmid containing formulation: chitosan as a protecting agent.

Authors:  Nasir Mohajel; Abdolhossein R Najafabadi; Kayhan Azadmanesh; Alireza Vatanara; Mohsen Amini; Esmail Moazeni; Amirabbas Rahimi; Kambiz Gilani
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

9.  Drying of a plasmid containing formulation: chitosan as a protecting agent.

Authors:  Nasir Mohajel; Abdolhossein R Najafabadi; Kayhan Azadmanesh; Mohsen Amini; Alireza Vatanara; Esmail Moazeni; Amirabbas Rahimi; Kambiz Gilani
Journal:  Daru       Date:  2012-09-03       Impact factor: 3.117

10.  Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids.

Authors:  Wanling Liang; Philip C L Kwok; Michael Y T Chow; Patricia Tang; A James Mason; Hak-Kim Chan; Jenny K W Lam
Journal:  Eur J Pharm Biopharm       Date:  2013-05-20       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.